ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,414,936, issued on Sept. 16, was assigned to CAAMTECH INC. (Issaquah, Wash.).

"Compositions comprising a serotonergic tryptamine compound" was invented by Andrew R. Chadeayne (Issaquah, Wash.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are compositions comprising a serotonergic tryptamine compound, combinations thereof, and methods of using them for treating and preventing a variety of human conditions. In one embodiment, disclosed herein are new compositions and methods which comprise a therapeutically effective amount of a first purified psilocybin derivative and a therapeutically effective amount of a second compound. The second ...